-
1 Comment
HPGC Renmintongtai Pharmaceutical Corporation is currently in a long term downtrend where the price is trading 9.9% below its 200 day moving average.
From a valuation standpoint, the stock is 95.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.4.
HPGC Renmintongtai Pharmaceutical Corporation's total revenue rose by 5.9% to $2B since the same quarter in the previous year.
Its net income has dropped by 92.2% to $5M since the same quarter in the previous year.
Finally, its free cash flow grew by 116.3% to $17M since the same quarter in the previous year.
Based on the above factors, HPGC Renmintongtai Pharmaceutical Corporation gets an overall score of 3/5.
| Sector | Healthcare |
|---|---|
| ISIN | CNE000000G05 |
| CurrencyCode | CNY |
| Industry | Drug Manufacturers-Specialty & Generic |
| Exchange | SHG |
| Beta | 0.63 |
|---|---|
| Dividend Yield | 0.0% |
| Target Price | None |
| Market Cap | 4B |
| PE Ratio | 14.17 |
HPGC Renmintongtai Pharmaceutical Corporation engages in the wholesale and retail of pharmaceutical products in China and internationally. The company offers Chinese medicines, Chinese herbal medicine, chemical preparations, antibiotics, biological products, and biochemical drugs, as well as medical equipment and health products. It also provides logistics services, including warehousing and distribution; and hospital services comprising medical treatment, scientific research, prevention, health care, rehabilitation, blood purification, and renal disease treatment. In addition, the company offers Chinese and Western medicines, Chinese herbal medicines, nourishing health care products, medical equipment, cosmetics, and daily necessities through an e-commerce platform. It operates 319 chain stores in Heilongjiang Province. The company was founded in 1950 and is headquartered in Harbin, China. HPGC Renmintongtai Pharmaceutical Corporation is a subsidiary of Harbin Pharmaceutical Group Co., Ltd.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 600829.SHG using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2024
